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Abstract Antibiotic resistance has impelled the
research for new agents that can inhibit bacterial growth
without showing cytotoxic effects on humans and other
species. We describe the synthesis and physicochem-
ical characterization of nanostructured ZnMgO whose
antibacterial activity was compared to its pure nano-
ZnO and nano-MgO counterparts. Among the three
oxides, ZnO nanocrystals—with the length of tetrapod
legs about 100 nm and the diameter about 10 nm—
were found to be the most effective antibacterial agents
since both Gram-positive (B. subtilis) and Gram-
negative (E. coli) bacteria were completely eradicated
at concentration of 1 mg/mL. MgO nanocubes (the
mean cube size *50 nm) only partially inhibited
bacterial growth, whereas ZnMgO nanoparticles (sizes
corresponding to pure particles) revealed high specific
antibacterial activity to Gram-positive bacteria at this
concentration. Transmission electron microscopy anal-
ysis showed that B. subtilis cells were damaged after
contact with nano-ZnMgO, causing cell contents to leak
out. Our preliminary toxicological study pointed out
that nano-ZnO is toxic when applied to human HeLa
cells, while nano-MgO and the mixed oxide did not
induce any cell damage. Overall, our results suggested
that nanostructured ZnMgO, may reconcile efficient
antibacterial efficiency while being a safe new thera-
peutic for bacterial infections.
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Introduction
Common pathogens, especially bacteria, remain a major
health concern responsible for causing a large number of
deaths and hospitalizations each year. The discovery of
antibiotics in the 1940s saved the lives of millions of
people. However, because of the widespread and
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sometimes inappropriate use of antibiotics, strains of
bacteria have begun to gain resistance to this type of
therapeutic. In industrialized countries, bacteria are
developing multiple resistances to a range of antibiotics,
which triggers a greater need for efficient antimicrobial
agents to which bacteria might not develop resistance.
Over the past decade, many potential antibacterial
agents—including nanometer-sized metal oxides—
have been researched. Some of these agents were
found to be cytotoxic against bacteria but not against
mammalian cells making, thus, medical applications
possible (Taylor and Webster 2011). The use of
inorganic nanoparticles has attracted lots of interest
mostly because of their reliable antimicrobial activity
found to be effective at low concentrations (Anagno-
stakos et al. 2008). This is due to their high specific
surface area which allows a broad range of reactions
with the bacterial surface. Therefore, it is not surpris-
ing that the antibacterial activity of metal oxide
nanoparticles is size-dependent.
Considerable antibacterial efficiency was observed
for ZnO, MgO, and Ti2O and attributed to the ability of
these nanoparticles to: (i) easily bind and damage the
bacterial membrane, (ii) penetrate the cell and bind to
a specific target, and (iii) generate reactive oxygen
species (ROS) on their surfaces that in turn provoke an
enhancement of the intracellular oxidative stress.
Compared to the organic molecules at a larger scale,
metal oxide nanoparticles reveal enhanced tempera-
ture stability and may attack bacteria via multiple
molecular mechanisms. As a consequence, bacteria
are unlikely to develop resistance against them since a
series of mutations of the microorganism would be
necessary in order to become resistant to the treatment.
Recent advances in nanotechnology of antibacterial
nanoparticles include incorporation of metal oxide
nanoparticles, especially TiO2, CuO, and ZnO into
diverse industrial, medical, and household products.
For instance, surfaces of dental and other implants
coated with TiO2 nanoparticles photocatalytically
oxidize various bacterial species, preventing postop-
erative infections (Rasmusson et al. 2005). However,
concern has been raised about the biocompatibility of
TiO2 nanoparticles (Lai et al. 2008). Nowadays,
studies are more focused on nanometer-sized metal
oxides that are assumed not to be toxic and exhibit
antibacterial activity that is not necessarily photoin-
duced as in the case of TiO2. These comprise
nanostructured ZnO, MgO, or CaO.
Nano-MgO was shown to exhibit bacteriocidal
activity which is highly dependent on the particle size
and concentration (Huang et al. 2005; Makhulf et al.
2005) and to act against both Gram-positive and Gram-
negative bacteria (Koper et al. 2002; Krishnamoorthy
et al. 2012; Makhulf et al. 2005). These nanoparticles
are considered as a promising novel antibacterial agent,
being harmless to mammalian cells and the environ-
ment. For instance, nano-MgO—alone or in combina-
tion with other microbials—was proposed as a
bacteriocide for treatment of food products in order to
improve microbiological food safety (Jin and He 2011).
Nanostructured ZnO is a highly efficient antibacterial
agent at significantly low concentrations showing, thus,
an advantage compared to nano-MgO. It was also found
to act against both, Gram-positive and Gram-negative
bacteria (Apperlot et al. 2009; Brayner et al. 2006;
Padamavathy and Vijayaraghavan 2008; Stoimenov
et al. 2002; Zhang et al. 2007). The mechanism proposed
implies that ZnO nanoparticles induce production of
ROS, bind to the bacterial membrane and penetrate into
bacterial cells. This cytotoxic effect was found to be
size-dependent: the smaller the particle size, the greater
the efficiency in inhibiting bacterial growth (Apperlot
et al. 2009). Despite numerous benefits regarding ZnO
antibacterial effects, some recent reports point out that
nano-ZnO may exhibit toxic effects on human cells (Lai
et al. 2008; Lyon et al. 2007; Taylor and Webster 2011).
We studied the antibacterial effects and toxicity on
mammalian cells of ZnMgO nanoparticles. The aim
was to combine the strong antibacterial activity of ZnO
with safe-to-use antibacterial activities of MgO. We
focused on E. coli (Gram-negative) and B. subtilus
(Gram-positive) cultures and compared antibacterial
activities of ZnMgO nanoparticles to those of nano-
MgO and nano-ZnO. Finally, toxicity on mammalian
cells was investigated for all three oxides. Obtained data
give the first indication that nano-ZnMgO mixed oxides
can be used as antibacterial agents and point to some
synergistic effects of its pure metal oxide components.
Experimental
Nanoparticles synthesis and characterization
Pure metal oxide nanoparticles (MgO and ZnO) were
produced by burning corresponding metal ribbons (Mg
and Zn; 99.9 %, Goodfellow) in a glove box made of
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stainless steel and rigid plastic which is designed to
afford vacuum (P * 1 mbar). For the production of
ZnMgO, a 5 wt% Mg/Zn alloy (Mg90/Zn10 5 wt%,
Goodfellow) was used. The combustion of metal, i.e.,
alloy ribbons was started by a thin Ni–Cr wire held in
contact with the extremity of the ribbon and which
could be resistively heated. For the purpose of
subsequent transmission electron microscopy (TEM)
measurements, a tweezer-type support holding TEM
grid was kept at a constant height (*10 cm) above the
sampling point, allowing the collection of particles near
the generation zone. The TEM analysis of the particles
was achieved by using a JEOL 2100 field emission
transmission electron microscope operated at 200 kV
with a 0.18 nm resolution. Before any type of mea-
surement, i.e., microscopic investigations and antibac-
terial and toxicological tests, powders were kept and
transported under a vacuum (P * 10-5 mbar) in order
to prevent any contact with the ambient air. X-ray
diffraction measurements were performed using a
PANalytical X’Pert PRO MRD diffractometer oper-
ated at 40 kV and 30 mA by means of the Cu Ka
radiation and with the scanning rate of 0.002941/s. For
the analysis of diffraction patterns, we used X’Pert
High Score Plus which is a suitable program for powder
diffraction and allows research in crystallographic data
base. Diffuse reflectance UV spectra were collected on
a Varian Cary 5000 UV–Vis–NIR spectrophotometer
and Kubelka–Munk model was used to derive the
absorbance values from the respective reflectances.
Bacteria and antibacterial test
Escherichia coli strain BL21 DE3 (Invitrogen, France)
and Bacilus subtilis 168 strain (kindly supplied by D.
Dobrijevic; MICALIS, INRA France) were used in
this study. Bacteria were cultivated in Luria–Bertani
(LB) medium containing 5 g/L of yeast extract, 10 g/L
bactotryptone, and 10 g/L NaCl. The saturated cul-
tures were diluted in fresh LB medium to initial optical
density (OD600) of 0.1 at 600 nm and incubated in a
shaking incubator (200 rpm) at 37 C. Bacteriological
tests were performed by measuring the growth curve
of liquid bacterial solutions incubated with nanopart-
icules. The growth curves were obtained after adding
nanoparticle powders to solutions containing E. coli or
B. subtilis (20 mL), by measuring the evolution of
optical density as a function of time. OD600 was
measured in 100 lL volume using Biophotometer
(Eppendorf). A blank containing the equivalent con-
centration of nanoparticles in LB medium incubated
under the same conditions was used as a control.
Transmission electron microscopy on bacteria
Bacterial cells at OD600 = 0.2 were mixed with nano-
particles (1 mg/mL) and incubated at 37 C for 5 h
under shaking (agitation 150 rpm). Ultrastructural visu-
alization of bacterial cells was carried out under a Zeiss
902 electron microscope. Bacterial cells were collected
on formal coated copper grids (Agar). After deposition
of bacterial suspension on the grids, grids were washed
twice with 10 mM sodium acetate buffer, pH 5, and fixed
with 2 % glutaraldehyde in PBS (phosphate buffered
saline) for 30 s. They were, then, rinsed twice with
sodium acetate buffer for 30 s, and finally negatively
stained with 1 % uranyl acetate water solution for 30 s.
Grids were air-dried before observation.
HeLa cells and cell death analysis
Human cervical epithelial HeLa cells (ATCC, USA) were
cultured in minimum essential medium (MEM) supple-
mented with Earle’s Salts without L-glutamine (PPA The
Cell Culture Company, Austria), completed with 10 %
heat-inactivated fetal calf serum (Perbio), 2 mM L-gluta-
mine, penicillin (100 units/mL), and streptomycin
(0.1 mg/mL). Cells were grown at 37 C and 5 % CO2.
Cell death in HeLa cells was quantified by acridine
orange staining followed by flow cytometry analysis
(Becton FACSCalibur, Dickinson and Company, USA)
with the488 nmlaser lineandFL-1channel.Thecellswere
trypsinized and centrifuged with the cell culture medium at
3,0009g for 5 min. Collected cells were washed two times
in PBS, then, resuspended in MEM containing acridine
orange (0.1 lg/mL) and incubated at 37 C for 10 min in
the dark. Stained cells were collected and washed two times
with PBS, and, then, fixed with 3.2 % PFA (paraformal-
dehyde) in PBS for 30 min. For analysis, the fixed cells
were collected at 5,0009g for 6 min, and resuspended in
PBS. The analysis was done on 5 9 104 cells.
The putative changes in the morphology of HeLa
cells treated with nanoparticles were compared to that
of corresponding untreated cells by acquiring bright
field images using Nikon TE200 inverted microscope
equipped with a Photometrics CoolSNAP ES2 cam-
era. Images were processed using MetaVue software
(Molecular Devices).
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Results and discussion
Synthesis and characterization of metal oxide
nanoparticles
The morphology of nanoparticles was characterized
by means of transmission electron microscopy. Rep-
resentative images of all three oxides are shown in
Fig. 1a. MgO nanoparticles (image with blue outline)
adopt regular cubic shape with an average particle size
of *50 nm that is typical for the synthesis condition
applied here (Stankic et al. 2011). Combustion of
metallic Zn in the air atmosphere results in nanopar-
ticles with two different shapes: nanorods and tetra-
pods (image with green outline). In tetrapods, four
arms project out at tetrahedral angles from a branching
point but the fourth ‘‘arm’’ is not visible on the selected
photo. Description is, however, based on several TEM
images taken with different angles (not shown here).
Length of either nanorods or tetrapod arms varies
Fig. 1 TEM images (a) and
X-ray diffraction patterns
(b) of ZnO (green), MgO
(blue), and ZnMgO (red)
nanoparticles
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between 150 and 200 nm, whereas the corresponding
diameters were measured to be *10 nm. TEM image
recorded on ZnMgO nanopowder (red outlined) shows
that in addition to cubically shaped nanoparticles
(marked with blue rectangles) also tetrapods and
nanorods (marked with green) were found. This
implies that the ZnMgO powder consists of structures
which are characteristic for its pure components—
MgO and ZnO. XRD patterns acquired on ZnO (green)
and MgO nanopowders (blue) fit perfectly to hexag-
onal and cubic structure, respectively (Fig. 1b) while
in the ZnMgO diffractogram (Fig. 1b, red) both, ZnO-
and MgO-specific reflexes were present. The similar-
ity in ionic radii between Mg2? (1.36 A˚) and Zn2?
(1.25 A˚) allows significant replacements in either
structure. Although the ZnMgO phase diagram (Segnit
and Holland 1965) and the wt% of ZnO in our mixed
sample (less than 5 %) correspond to cubic crystal
structure of the mixed oxide both, TEM images and
XRD unambiguously demonstrate that the phase
separation—most probably as a consequence of syn-
thesis technique applied here—occurs in the mixed
oxide.
UV/Vis diffuse reflectance (optical absorption)
spectra of MgO, ZnO, and composite ZnMgO nano-
powders are presented in Fig. 2. In comparison to the
UV diffuse reflectance spectra of the MgO sample
(blue curve), the spectrum of the ZnMgO sample
shows Zn2?-induced changes in the absorption prop-
erties (red curve). These changes are either character-
ized by a slightly red-shifted absorption band or an
absorption threshold at 3.4 eV which is consistent
with the band gap of ZnO (green curve) (Klingshirn
2007). The latter observation is supported by previ-
ously discussed XRD and TEM results and conclusion
that the phase separation into MgO-rich cubic phase
and ZnO-rich wurtzite phase should have occurred
during the combustion synthesis where the particles
are exposed to high temperatures. Although two
phases are observed in TEM images (Figs. 1, 2) we
cannot totally rule out the possibility that Zn is
partially integrated into MgO cubes and vice versa.
However, regarding the relatively week percentage of
Zn (less than 5 %) and the appearance of particle
shapes typically found in pure powders—tetrapods in
ZnO and cubes in MgO—we assume that ZnMgO
powder mainly consists of pure and separated com-
ponents. Finally, also energy-dispersive X-ray spec-
troscopy has shown no presence of Zn-atoms in MgO
cubes and vice versa but, since this method is typically
sensitive down to levels of 0.1 atomic percent we
cannot exclude the existence of solid solutions up to
this percentage range.
Antibacterial effects of ZnO, MgO, and ZnMgO
nanoparticles
First, we tested the antimicrobial activities of nano-
particles at different concentrations (0.001—1 mg/
mL) against E. coli and B. subtilis in LB medium (data
not shown). After 5 h treatment, nano-ZnO-inhibited
growth of both bacteria in a concentration-dependent
manner, showing complete bacteriocidal effect for
concentrations above 0.1 mg/mL. In contrast, bacte-
rial incubation for 5 h with nano-MgO or nano-
ZnMgO resulted in a relatively small rate of bacterial
growth inactivation for a concentration lower than
1 mg/mL. Thus, to further compare antibacterial
effects of nanoparticles, concentrations of 1 mg/mL
were used for all three types of metal oxide
nanoparticles.
Figure 3 shows kinetic effects of the nano-metal
oxides on E. coli and B. subtilis growth curves. Within
less than 1 h, ZnO nanoparticles completely eradi-
cated bacteria in both cultures, whereas MgO nano-
cubes reduced viability of E. coli and B. subtilis by 89
and 78 %, respectively, after 5 h of treatment. Fluc-
tuations of optical density in Fig. 3 originated from
bacterial precipitation and variation of the cell number
charged into the spectroscopic cuvette. The smallest
antibacterial efficiency was found for ZnMgO
Fig. 2 Room temperature diffuse reflectance UV/Vis spectra of
ZnO (green), MgO (blue), and ZnMgO (red) nanoparticles
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nanoparticles; the viability of E. coli and B. subtilis
was found to be reduced by 61 and 25 %, respectively,
after 5 h treatment. This result suggests that the mixed
oxide exhibits reduced kinetics of antibacterial activ-
ity with respect to either pure component.
We then quantified bacterial viability after 24 h
incubation with nanoparticles (Fig. 4). As expected,
there were no surviving bacteria in the medium
containing ZnO nanoparticles. Treatment with nano-
MgO particles resulted in 53 % survival of E. coli, and
only 21 % of B. subtilis. Surprisingly, under the same
conditions ZnMgO nanoparticles completely inacti-
vated the growth of B. subtilis, while about 80 % E. coli
survived this treatment. Comparing these to the results
obtained in kinetic tests above, it is obvious that the
ZnMgO system exhibits different antibacterial kinetic
with respect to pure ZnO and needs more than 5 h to be
sufficiently active. Moreover, this result indicates not
only the high antibacterial activity of ZnMgO mixed
system but it implies also its selectivity against Gram-
positive bacteria. This may be explained by differences
in cell wall structure between Gram-positive and Gram-
negative bacteria implying that ZnMgO exhibits higher
binding affinity to Gram-positive bacteria cell wall.
Several mechanisms have been reported for the anti-
bacterial activity of metal oxide nanoparticles. One of
these is to bind to the cell membrane of microorganisms
due to their high affinity to interact with membrane
lipids, such as phospholipids (Krishnamoorthy et al.
2012; Zhang et al. 2007). When interacting with the
membrane, nanoparticles can disorganize the mem-
brane structure and dynamics. This leads to the lost of
membrane integrity, malfunction, and finally to bacte-
rial death. Being Gram-positive bacteria B. subtilis has
only a single unit lipid membrane, in contrast to Gram-
negative E. coli which has a cytoplasmic membrane and
an outer cell membrane. We may, therefore, suggest
that selective antibacterial activity of nano-ZnMgO
against B. subtilis is, when compared to E. coli, related
to specific bacterial membrane lipid composition and
total charge, and/or different membrane layer thickness
and structure.
There are, furthermore, studies which have shown
that at nanoscale level ZnO and MgO may also
Fig. 3 Growth curves of
E. coli (a) and B. subtilis
(b) in Luria–Bertani (LB)
medium in the presence of
1 mg/mL: ZnO (green),
MgO (blue), or ZnMgO
(red) nanoparticles
Fig. 4 Antibacterial efficiency of ZnO, MgO, and ZnMgO nanoparticles at 1 mg/mL tested on E. coli (a) and B. subtilis (b) after 24 h
incubation. Note that ZnO completely eliminates both bacteria’s strains while ZnMgO eliminates only B. subtilis
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penetrate into bacterial cells and produce there toxic
oxygen radicals (Apperlot et al. 2009; Irzh et al. 2010;
Makhulf et al. 2005; Zhang et al. 2007). In aqueous
solutions, both MgO and ZnO nano-components
produce peroxides that may act as oxidizing agents.
These ROS can damage DNA, cell membrane, or cell
proteins, and may lead to the inhibition of bacterial
growth and eventually to bacterial death (Moody and
Hassan 1982). Some bacteria are more resistant to
oxidative stress by producing protective enzymes,
such as super oxide dismutase or catalase which
neutralize reactive oxidative species. To elucidate
between the two proposed mechanisms, interaction of
water with ZnMgO needs to be studied. This is,
however, in the domain of surface science chemistry
and exceeds the scope of the present paper.
Transmission electron microscopy was applied in
order to evidence possible changes at bacterial mem-
branes upon their interactions with metal oxide
nanoparticles. In medium free of metal oxide nano-
particles, B. subtilis were in linear phase of multipli-
cation, so that the most bacteria observed were in
division, as illustrated in Fig. 5a. The untreated
bacterial cells were in rod shapes of normal size of
about 1 lm with intact cell structure. In Fig. 5b–d, we
show TEM images of B. subtilis treated for 5 h with
ZnO, MgO, and ZnMgO nanocrystals. Admixture of
MgO nanocubes to the medium-induced morpholog-
ical changes of bacteria cells at the membrane level
(Fig. 5b). Those changes reflect the formation of
irregular cell surface and alteration of cell membrane.
However, B. subtilis were observed in cell division
phase, as untreated bacteria, indicating that crucial
steps in cell division process were not inhibited by the
presence of MgO nanocubes.
Curiously, when ZnO nanocrystals were added to
the bacterial solution, almost no integral cell was
observed. Instead, flagella disconnected from bacteria
can be seen as well as some high density material,
suggesting the leakage of the internal cell contents
(Fig. 5c). A similar effect of ZnO nanoparticles on
bacterial cell walls was previously shown by Brayner
et al. (2006). We hypothesize that significantly sharp
shapes of our ZnO nanorods and nanotetrapods, both
found to have *10 nm diameter, easily damage the
membrane integrity allowing in addition faster pene-
tration of nanoparticles into bacterial cells. Moreover,
TEM images insert in Fig. 5c show flagella associated
with nanoparticles suggesting that this metal oxide
binds not only membrane lipids but also proteins from
flagella.
Finally, TEM analysis showed that ZnMgO nano-
particles cause extensive injury of the bacterial cell
membrane and complex morphological changes. As
illustrated in Fig. 5d, bacterial cells treated with nano-
ZnMgO shrunk to smaller and more rounded shapes
than untreated cells (Fig. 5a). In addition, the cell
membrane appears to have a more irregular rough
surface. The inhomogeneous appearance of the cyto-
plasm might be a result of the leakage of the cell
content. Moreover, some cellular debris associated
Fig. 5 TEM images of untreated B. subtilis (a) and treated B.
subtilis with ZnO (b), MgO (c), and ZnMgO (d) nanoparticules
(for 5 h, at concentration 1 mg/mL)
J Nanopart Res (2013) 15:1595 Page 7 of 10
123
Fig. 6 Left panel optical
images of (a) untreated
HeLa cells (Mock) and
HeLa cells treated with
(b) MgO (blue outline),
(c) ZnO (green outline), and
(d) ZnMgO nanoparticles
(24 h, 1 mg/mL). Right
panel quantification of the
cytotoxic effect of
nanoparticles on HeLa cells
by acridine orange staining
and flow cytometry analysis
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with the nanoparticles was also detected. This finding
also implies that nano-ZnMgO possibly provokes an
internal cellular content leak. Complementary studies
are needed to elucidate the molecular mechanism by
which mixed ZnMgO damages bacteria.
Cytotoxicity analysis
Nanoparticles are promising agents for antibacterial
applications only if they are toxic to bacteria but not
mammalian cells. Indeed, some antibacterial nanopar-
ticles can be phagocytosed and subsequently degraded
by lysosomal fusion and thus appear non-toxic to
mammalian cells (Arbab et al. 2005; Taylor and
Webster 2011). We used HeLa cells to probe the
cytotoxic effects of ZnO, MgO, and ZnMgO on
mammalian cells. The cells were treated with metal
oxide nanoparticles at a concentration of 1 mg/mL for
24 h, at optimal conditions for antibacterial activity.
Treated HeLa cells were firstly analyzed via optical
microscopy. Figure 6 left panel displays representative
images of treated cells. No changes with respect to the
morphology and density of HeLa cells could be
observed after incubations with nano-MgO or nano-
ZnMgO, whereas the ZnO treatment led to the death of
all cells. To support these findings, a quantification of
cell death was performed on treated HeLa cells (24 h
incubation) by acridine orange staining (Dar-
zynkiewicz and Kapuscinski 1990) and flow cytometry
analysis (Fig. 6 right panel). The reduction of acridine
orange derived fluorescence intensity in cells indicated
that ZnO nanoparticles induce cell death in more than
97 % of treated HeLa cells. On the contrary, only about
10 % of cell mortality was observed after treatment
with either nano-MgO or nano-ZnMgO. In control
experiments, untreated HeLa cells presented about
5 % cell mortality. The quantitative cell death analysis
data are, therefore, consistent with the observation
made by optical microscopy, suggesting that MgO and
ZnMgO nanoparticles—when compared to ZnO nano-
particles—are significantly less toxic to mammalian
cells. These results are perfectly in line with the
previous study on pure nano-ZnO and nano-MgO
cytotoxic effect on human neural cells and fibroblasts
(Lai et al. 2008). They found that nano-ZnO was more
effective in inducing cellular death than nano-MgO.
Overall, our results suggest that ZnMgO nanopar-
ticles possess a strong antibacterial effect toward
Gram-positive bacteria but do not affect the cell
viability of HeLa. TEM analysis implies that ZnMgO
nanocrystals bind to bacterial membrane causing
membrane disruption. On the contrary, HeLa cells
found the way to neutralize their toxic effect and there
is no membrane damage. We assume that the HeLa cell
uptakes ZnMgO nanoparticles and metabolize them—
which finally leads to the neutralization of their
toxicity. Similar effect was shown for iron-oxide
nanoparticles which can be internalized into eno-
some/liposomes and degraded there (Arbab et al.
2005). Nano-Ag2O3 is, also, not toxic to mammalian
fibroblast L929 and BJ cells at concentrations having
antibacterial activity (Radziun et al. 2011). Nano-
Ag2O3 of 50–80 nm size penetrates fibroblast cells
without affecting cell viability or inducing apoptosis.
Similarly, when nano-Ag2O3 was used to stabilize
nano-Ag or nano-Pr, no phyto- or eco-toxicity was
observed (Jastrze˛bska et al. 2012). Our cytotoxic
analysis suggests no toxic effect of ZnMgO, and thus
potentially its good biocompatibility. Further detailed
study is, however, needed to elucidate both, the
antibacterial mechanism and significant selectivity of
ZnMgO nanoparticles.
Conclusions and perspectives
Antibacterial and toxicological impacts of ZnMgO
mixed nanoparticles were studied and compared to
those of pure ZnO and MgO nanoparticles. For this
purpose, pure nanoparticles as well as their mixture—
with Zn content lower than 5 wt%—were synthesized
via a metal combustion technique. Transmission elec-
tron microscopy shows that ZnMgO powder consists of
nanocubes, nanorods, and nanotetrapods; structures
which were also observed in its pure components.
Focusing on both, Gram-positive and Gram-negative
bacteria, we show that among three studied oxides,
ZnO nanorods and nanotetrapods reveal the highest
antibacterial efficiency while being toxic to mamma-
lian cell—as demonstrated on HeLa cells. On the
contrary, MgO nanocubes inhibit only partially bacte-
rial growth being at the same time harmless to
mammalian cells. Finally, mixed ZnMgO nanoparti-
cles reveal synergetic effects of the pure components:
no damages on mammalian cells were observed—
similarly as for pure MgO whereas they show strong
antibacterial activity—comparable to pure ZnO—
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which is in addition highly selective for Gram-positive
bacteria. Complementary studies are in progress and
they aim to: (i) monitor bacterial growth in the presence
of ZnMgO varying Zn/Mg ratio, sizes and shapes, (ii)
determine the molecular mechanism of antibacterial
effects of nano-ZnMgO, and (iv) extend toxicological
studies on other types of mammalian cells.
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